We also evaluated, in a limited number of samples, whether the effect the of anti-IL17 therapeutic blockade on cell is specific for anti-IL-17 biologics or a similar effect is mediated after treatment of psoriasis patients with other agents. The gene discussed is IL17A; the disease is psoriasis.